Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch from zidovudine/lamivudine to Truvada for peripheral fat redistribution in virologically suppressed adults with HIV-1
ISRCTN81993634Phase 4Completed
- Sponsor
- Gilead Sciences
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Human immunodeficiency virus infection type 1 comparing Switch to Truvada with Continue zidovudine + lamivudine backbone (2 arms). Primary endpoints: Change in limb fat at week 48, DEXA scan assessments and 1 more. Started Apr 2006; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxilzidovudinelamivudine
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on ISRCTN81993634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN81993634.